Purchase Order 75N95024P00593
Award Date
9/15/24
Potential Completion Date
5/31/25
Potential Value
$247K
Funding Federal Agency
National Institute on Aging
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Alamar Biosciences, Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
B537 - Special Studies/Analysis- Medical/Health
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fremont, CA 94538, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency, to Alamar Biosciences, Inc. for the ALAMAR NULISASEQ INFLAMMATION PANEL 250 REAGENTS. The contract has a ceiling value of $324,000.00 and a period of performance through July 7, 2025. Alamar Biosciences, Inc. is a for-profit manufacturer of specialized biomedical research tools and services, with a focus on diagnostic technologies for central nervous system disorders like...
This firm-fixed-price purchase order was awarded by the National Institute on Aging (NIA), a civilian federal agency, to Alamar Biosciences, Inc., a for-profit manufacturer of goods. The $92,000.00 contract is for the delivery of a "SINGLE-PLEX NULISAPCR ABSOLUTE QUANTIFICATION ASSAY OF HDGFL2 IN PLASMA SAMPLES." This contract supports the agency's research into Alzheimer's disease and central nervous system (CNS) disorders, as Alamar Biosciences specializes in providing advanced...
<p>The National Institute on Aging, a civilian federal agency, awarded a $17,500.00 Firm Fixed Price Purchase Order to Alamar Biosciences, Inc. to provide laboratory and testing services for the NULISASEQ CNS Disease Panel service. The award has an ultimate completion date of August 11, 2024. The contract does not have a set-aside designation.</p>
This is a $2,640,000 firm-fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Amprion, Inc., a for-profit organization. The contract is for protein analysis services on cerebrospinal fluid samples to detect the presence or absence of alpha-synuclein aggregates, which are associated with neurodegenerative diseases like Alzheimer's and Parkinson's. This contract is not set-aside and...
The National Institute on Aging (NIA) awarded a $97,757.34 firm fixed-price purchase order to Fujirebio US, Inc. to provide assay kits for the Lumipulse G1200 instrument. The purpose is to leverage existing data on neuroimaging, cognitive, and clinical factors to understand cognitive and brain changes in healthy individuals and those with comorbidities. The original sources sought notice indicated the government was looking to acquire state-of-the-art assay kits for quantification of...
This is a $199,812 firm fixed price purchase order awarded by the National Institutes of Health's (NIH) National Institute on Aging (NIA) to QPS Austria GMBH, a contract research organization. The contract is for in vivo efficacy studies of a candidate Alzheimer's treatment in a transgenic mouse model. This award is part of the NIA's Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study, which aims to identify FDA-approved drugs that may be repurposed as disease-modifying...
This is a firm-fixed price purchase order contract awarded by the National Institute on Aging, a civilian agency within the National Institutes of Health, to Amprion, Inc. for $1,064,800.00. The contract is for protein analysis services on 1,648 cerebrospinal fluid samples to detect the presence or absence of alpha synuclein seeds using the Amprion SYNTap assay. The contract has a period of performance of one year and does not have a set-aside designation. The contract was awarded on July 3,...
This is a firm fixed-price delivery order contract awarded by the National Institute on Aging (NIA), a civilian federal agency, to Scantox Neuro GMBH, a for-profit organization based in Austria. The contract, valued at $858,106.08, is for the experimental validation of candidate Alzheimer's disease treatments identified through multi-omics analyses. This work supports ongoing NIA research initiatives such as the Drug Repurposing for Effective Alzheimer's Medicines (DREAM) and PREVENT-AD studies....
This is a firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a part of the National Institutes of Health (NIH), to Singulomics Corp, a biotechnology company specializing in single cell omics research and services. The $27,893 contract is for DNA single cell sequencing of mouse tissue specimens to support NIA's research on Alzheimer's disease and related dementias. The period of performance is from July 19, 2021 to December 1, 2021. This contract was not set aside...
<p>The National Institute on Aging, a civilian federal agency, awarded a firm-fixed-price purchase order contract to Alamar Biosciences, Inc. to provide the ARGO HT INSTRUMENT AND NULISASEQ CNS DISEASE PANEL. The $2,751,760.00 contract has a period of performance through September 17, 2025. This contract does not have a set-aside designation. Alamar Biosciences, Inc. is a for-profit manufacturer of goods.</p>